{"id":27445,"date":"2024-10-15T10:28:15","date_gmt":"2024-10-15T08:28:15","guid":{"rendered":"https:\/\/ggba.swiss\/lymphatica-medtech-secures-eur-17-9-million-to-advance-lymphedema-treatment\/"},"modified":"2024-10-15T10:30:31","modified_gmt":"2024-10-15T08:30:31","slug":"lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/","title":{"rendered":"Lymphatica Medtech l\u00e8ve EUR 17,9 millions pour son traitement du lymph\u0153d\u00e8me"},"content":{"rendered":"\n<p>Le dispositif phare de <a href=\"https:\/\/lymphaticamedtech.com\/\">Lymphatica Medtech<\/a>, LymphoDrain, constitue une perc\u00e9e dans le traitement du lymph\u0153d\u00e8me. Implant\u00e9e par voie sous-cutan\u00e9e \u00e0 l&rsquo;aide d&rsquo;une technique mini-invasive, cette solution remplace la fonction naturelle des vaisseaux lymphatiques et draine activement le liquide lymphatique afin de r\u00e9duire l&rsquo;enflure et de soulager les patients. Il s&rsquo;agit l\u00e0 d&rsquo;une avanc\u00e9e majeure dans les options de traitement du lymph\u0153d\u00e8me, qui se limitent actuellement \u00e0 des th\u00e9rapies limit\u00e9es et souvent inefficaces.<\/p>\n\n\n\n<p>Le tour de table a \u00e9t\u00e9 co-dirig\u00e9 par <a href=\"https:\/\/www.panakes.it\/\">Panak\u00e8s Partners<\/a>, <a href=\"https:\/\/www.techwald.com\/\">TechWald Next S.p.A.<\/a> et <a href=\"https:\/\/www.cdpventurecapital.it\/cdp-venture-capital\/\">CDP Venture Capital&rsquo;<\/a>s Digital Transition Fund, avec la participation d&rsquo;<a href=\"https:\/\/www.occident.group\/\">OCCIDENT<\/a>, de la <a href=\"http:\/\/www.zkb.ch\/\">Z\u00fcrcher Kantonalbank<\/a> et du <a href=\"https:\/\/www.clubdeglinvestitori.it\/\">Club Degli Investitori<\/a>. Des investisseurs existants, dont le High-Tech Gr\u00fcnderfonds (<a href=\"https:\/\/www.htgf.de\/\">HTGF<\/a>), ont \u00e9galement particip\u00e9 \u00e0 ce tour de table.<\/p>\n\n\n\n<p>L&rsquo;investissement soutiendra \u00e9galement l&rsquo;expansion internationale de Lymphatica avec l&rsquo;ouverture d&rsquo;une nouvelle filiale en Italie pour g\u00e9rer la recherche et le d\u00e9veloppement (R&amp;D), la fabrication et les op\u00e9rations cliniques. Cette d\u00e9cision renforce la capacit\u00e9 de l&rsquo;entreprise \u00e0 r\u00e9pondre \u00e0 la demande croissante et \u00e0 d\u00e9velopper ses solutions innovantes.<\/p>\n\n\n\n<p>L&rsquo;\u00e9quipe dirigeante de Lymphatica a \u00e9t\u00e9 renforc\u00e9e par la nomination de Dan Rose au poste de pr\u00e9sident du conseil d&rsquo;administration. M. Rose apporte \u00e0 cette \u00e9quipe sa vaste exp\u00e9rience acquise dans le cadre de ses fonctions pr\u00e9c\u00e9dentes chez LimFlow, Direct Flow Medical et Medtronic. Les autres nouveaux membres du conseil d&rsquo;administration sont Alessio Beverina, associ\u00e9 g\u00e9rant chez Panak\u00e8s, et Lukas Guenther, directeur des investissements chez TechWald Next.<\/p>\n\n\n\n<p>Dr Marco Pisano, CEO et cofondateur de Lymphatica, s&rsquo;est montr\u00e9 enthousiaste quant \u00e0 l&rsquo;avenir de l&rsquo;entreprise : \u00ab Ce financement nous permet de poursuivre le d\u00e9veloppement clinique de notre technologie, ce qui nous rapproche d&rsquo;une solution transformatrice pour les patients souffrant de lymph\u0153d\u00e8me. \u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lymphatica Medtech, une soci\u00e9t\u00e9 lausannoise en phase clinique sp\u00e9cialis\u00e9e dans les traitements innovants du lymph\u0153d\u00e8me, a lev\u00e9 EUR 17,9 millions dans le cadre d&rsquo;un tour de financement de s\u00e9rie B.<\/p>\n","protected":false},"author":6,"featured_media":27442,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1148,1188,1181,1140,1141],"class_list":["post-27445","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-oncology-fr-2","tag-personalized-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lymphatica Medtech l\u00e8ve EUR 17,9 millions | GGBa<\/title>\n<meta name=\"description\" content=\"Lymphatica Medtech, une soci\u00e9t\u00e9 en phase clinique sp\u00e9cialis\u00e9e dans les traitements du lymph\u0153d\u00e8me, a lev\u00e9 EUR 17,9 millions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lymphatica Medtech l\u00e8ve EUR 17,9 millions | GGBa\" \/>\n<meta property=\"og:description\" content=\"Lymphatica Medtech, une soci\u00e9t\u00e9 en phase clinique sp\u00e9cialis\u00e9e dans les traitements du lymph\u0153d\u00e8me, a lev\u00e9 EUR 17,9 millions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-15T08:28:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-15T08:30:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Lymphatica Medtech l\u00e8ve EUR 17,9 millions pour son traitement du lymph\u0153d\u00e8me\",\"datePublished\":\"2024-10-15T08:28:15+00:00\",\"dateModified\":\"2024-10-15T08:30:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/\"},\"wordCount\":334,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Oncology\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/\",\"name\":\"Lymphatica Medtech l\u00e8ve EUR 17,9 millions | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg\",\"datePublished\":\"2024-10-15T08:28:15+00:00\",\"dateModified\":\"2024-10-15T08:30:31+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Lymphatica Medtech, une soci\u00e9t\u00e9 en phase clinique sp\u00e9cialis\u00e9e dans les traitements du lymph\u0153d\u00e8me, a lev\u00e9 EUR 17,9 millions.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Lymphatica Medtech est une soci\u00e9t\u00e9 qui s'est engag\u00e9e \u00e0 am\u00e9liorer de mani\u00e8re significative le bien-\u00eatre des patients souffrant de maladies lymphatiques gr\u00e2ce \u00e0 des produits innovants qui remplacent efficacement la fonction de drainage lymphatique sans alt\u00e9rer le mode de vie du patient. | \u00a9 Lymphatica Medtech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lymphatica Medtech l\u00e8ve EUR 17,9 millions pour son traitement du lymph\u0153d\u00e8me\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lymphatica Medtech l\u00e8ve EUR 17,9 millions | GGBa","description":"Lymphatica Medtech, une soci\u00e9t\u00e9 en phase clinique sp\u00e9cialis\u00e9e dans les traitements du lymph\u0153d\u00e8me, a lev\u00e9 EUR 17,9 millions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/","og_locale":"fr_FR","og_type":"article","og_title":"Lymphatica Medtech l\u00e8ve EUR 17,9 millions | GGBa","og_description":"Lymphatica Medtech, une soci\u00e9t\u00e9 en phase clinique sp\u00e9cialis\u00e9e dans les traitements du lymph\u0153d\u00e8me, a lev\u00e9 EUR 17,9 millions.","og_url":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-10-15T08:28:15+00:00","article_modified_time":"2024-10-15T08:30:31+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Lymphatica Medtech l\u00e8ve EUR 17,9 millions pour son traitement du lymph\u0153d\u00e8me","datePublished":"2024-10-15T08:28:15+00:00","dateModified":"2024-10-15T08:30:31+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/"},"wordCount":334,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg","keywords":["Financing","Healthcare","Medical Devices","Oncology","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/","url":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/","name":"Lymphatica Medtech l\u00e8ve EUR 17,9 millions | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg","datePublished":"2024-10-15T08:28:15+00:00","dateModified":"2024-10-15T08:30:31+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Lymphatica Medtech, une soci\u00e9t\u00e9 en phase clinique sp\u00e9cialis\u00e9e dans les traitements du lymph\u0153d\u00e8me, a lev\u00e9 EUR 17,9 millions.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/10\/Lymphatica-Medtech-1180x811-1.jpeg","width":1180,"height":811,"caption":"Lymphatica Medtech est une soci\u00e9t\u00e9 qui s'est engag\u00e9e \u00e0 am\u00e9liorer de mani\u00e8re significative le bien-\u00eatre des patients souffrant de maladies lymphatiques gr\u00e2ce \u00e0 des produits innovants qui remplacent efficacement la fonction de drainage lymphatique sans alt\u00e9rer le mode de vie du patient. | \u00a9 Lymphatica Medtech"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/lymphatica-medtech-leve-eur-179-millions-pour-son-traitement-du-lymphoedeme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Lymphatica Medtech l\u00e8ve EUR 17,9 millions pour son traitement du lymph\u0153d\u00e8me"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=27445"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27445\/revisions"}],"predecessor-version":[{"id":27447,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/27445\/revisions\/27447"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/27442"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=27445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=27445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=27445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}